Concepedia

Peter Shaw

PS

Statistics

Publications

69

Citations

5K

H-Index

34

Active since

1971

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bristol-Myers Squibb (United States)

United States Military Academy

Google (United States)

Lebanese American University

Peter Shaw is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and cytochrome p450 enzymes.

Publications per year

1971–2023

69

Publications

69

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Yudi Pawitan, Judith Bjöhle, Lukas C. Amler et al. · Breast Cancer Research · 2005 · 834 citations · Full text

Medicine, Cancer Biology, Oncology +17

MAIT cells are activated during human viral infections

Bonnie van Wilgenburg, Iris Scherwitzl, Edward Hutchinson et al. · Nature Communications · 2016 · 521 citations · Full text

Life Sciences, Immunology, Microbiology +17

Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection

Fei Huang, Karen A. Reeves, Xia Han et al. · Cancer Research · 2007 · 343 citations · Full text

Medicine, Oncology, Pharmacology +17

EMT is the dominant program in human colon cancer

Andre Loboda, Michael Nebozhyn, James Watters et al. · BMC Medical Genomics · 2011 · 278 citations · Full text

Medicine, Molecular Biology, Oncology +17

Self-Attention with Relative Position Representations

Peter Shaw, Jakob Uszkoreit, Ashish Vaswani · 2018 · 272 citations · Full text

Computing, Computer Science, Linguistics +8

1–5 of 69